The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma
- 31 July 2019
- journal article
- research article
- Published by Informa UK Limited in Nanomedicine
- Vol. 14 (15), 2027-2043
- https://doi.org/10.2217/nnm-2019-0094
Abstract
Aim: To clarify the effectiveness and safety of x-ray-activated photodynamic therapy (X-PDT) for cutaneous squamous cell carcinoma (SCC) and melanoma. Materials & methods: Copper-cysteamine nanoparticles were used as a photosensitizer of X-PDT. The dark toxicity and cytotoxicity were studied in vitro. Tumor volume, microvessel density and acute toxicity of mice were evaluated in vivo. Results: Without x-ray irradiation, copper-cysteamine nanoparticles were nontoxic for keratinocyte cells. XL50 cells (SCC) were more sensitive to X-PDT than B16F10 cells (melanoma). X-PDT successfully inhibited the growth of SCC in vivo (p < 0.05), while the B16F10 melanoma was resistant. Microvessel density in SCC tissue was remarkably reduced (p < 0.05). No obvious acute toxicity reaction was observed. Conclusion: X-PDT is a safe and effective treatment for SCC.Keywords
This publication has 61 references indexed in Scilit:
- Therapeutic enhancement of vascular-targeted photodynamic therapy by inhibiting proteasomal functionCancer Letters, 2013
- In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticlesInternational Journal of Nanomedicine, 2013
- Melanoma resistance to photodynamic therapy: new insightsBiological Chemistry, 2013
- Management of radiation woundsIndian Journal of Plastic Surgery, 2012
- Tumor Vascular Microenvironment Determines Responsiveness to Photodynamic TherapyCancer Research, 2012
- Squamous cell carcinoma (Marjolin's ulcer) in an orocutaneous fistula of a large mandibular ameloblastoma: a case reportJournal of Medical Case Reports, 2011
- Redox Reactions of the α-Synuclein−Cu2+ Complex and Their Effects on Neuronal Cell ViabilityBiochemistry, 2010
- The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting AgentsCancer Treatment Reviews, 2010
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- THE EFFECTS OF THROMBOXANE INHIBITORS ON THE MICROVASCULAR AND TUMOR RESPONSE TO PHOTODYNAMIC THERAPYPhotochemistry and Photobiology, 1993